Infectious Disease
RSSArticles
-
Biventricular Hypertrophy in an Asymptomatic Patient?
-
Eravacycline Injection (Xerava)
The FDA has approved a new parenteral, broad-spectrum antibiotic in the tetracycline class for the treatment of complicated intra-abdominal infections.
-
Home-based Detection of Undiagnosed Atrial Fibrillation
In patients with risk factors for atrial fibrillation, screening with a self-applied wearable ECG patch resulted in significantly increased rates of new atrial fibrillation diagnoses within four months, along with greater use of anticoagulants and healthcare resources.
-
Are In-hospital Deaths Related to Community-acquired Pneumonia Preventable?
This secondary analysis of data from five tertiary care centers found that among patients hospitalized for community-acquired pneumonia, very few deaths potentially were related to a lapse in in-hospital quality of pneumonia care.
-
Revised Anticoagulation Therapy Guidelines for Atrial Fibrillation Patients
More patients with atrial fibrillation may receive anticoagulation, according to new recommendations.
-
EMTs Treating Opioid Patients Succumb to Illness
Infection preventionists are striving to prevent opioid outbreaks related to drug diversion by healthcare workers. Those with a second hat in employee health are no doubt aware of another threat that is almost as insidious: EMTs becoming sick after treating opioid overdose patients. -
CDC: New Flu Vaccine Ready After Harsh 2017-2018 Season
On the heels of a brutal 2017-2018 flu season, the vaccine strains for the 2018-2019 season have been set. -
FDA Adds New Safety Warning for Fluoroquinolones
Adding another in a series of label warnings for fluoroquinolones, the FDA is emphasizing that the antibiotics pose too high a risk of patient harm to be used for relatively minor infections. -
Joint Commission Revises IC Devices Standard
The changes generally add more detailed instructions for surveyors, focus on the highest risk to patients, and note that the hang time of endoscopes will not be assessed anymore as an infection control requirement. -
‘Why the Foley?’ Initiative Grabs Attention, Prevents CAUTIs
Not everyone was pleased with the provocative acronym, but an infection preventionist’s “Why the Foley?” campaign captured attention and dramatically reduced catheter-associated urinary tract infections.